Virmedex beneficiary of the European Women TechEU Cohort
CEO Dani Tost selected among Europe's top female tech founders, securing an exclusive growth accelerator grant.
BRUSSELS / BARCELONA //
The European Innovation Council has officially announced that Dr. Daniela Tost, CEO of Virmedex, has been selected as a beneficiary of the highly competitive Women TechEU scheme.
The initiative supports deep-tech startups led by women, providing non-dilutive financial support alongside premium coaching and corporate networking.
Out of hundreds of applications across Europe, Virmedex’s cloud-based clinical simulation framework was highly commended for its technical merit and social impact.
More news
Virmedex: When Video Games Save Lives in the Operating Room
Specialist portal Aware.Doctor analyzes Virmedex's brand identity, 3D design language, and its educational philosophy of building resilience through controlled mistakes in virtual environments.
Read the article →
Virmedex Awarded the City of Barcelona Prize for Applied Innovation
Academic and public media celebrate Virmedex receiving the City of Barcelona Prize for its outstanding achievements in applied technological innovation within the healthcare sector.
Read the article →
Rapid adoption across United States medical programs validates the cloud educational model, paving the way for a Series A round.
Virmedex announces the growth of its software subscriptions in European hospitals and US universities, moving forward with strategic preparations to open a second funding round in mid-2026.
Read the article →